Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US FDA’s Plan On Right To Try: Big On Congressional Engagement, Short On Policy Details

Executive Summary

Internal group headed by Principal Deputy Commissioner Rachel Sherman will develop implementation recommendations, which could include new guidance, regulations, a Q&A document or ‘nothing at all,’ Commissioner Gottlieb tells BIO annual meeting; he promises consultation with the law’s supporters and critics on Capitol Hill ‘to fully understand what the intent was with different provisions.’

Advertisement

Related Content

Expanded Access: US FDA Told To Increase Regulatory Clarity, Early Interactions With Sponsors
Panel Of Former US FDA Commissioners Make Renewed Call For Independent Agency
Gottlieb's "Right To Try" Sentiment: Law Fails To Address Difficulties Faced By Drugmakers
Why The Right-To-Try Law Is Not Right For Some Biotech Companies
US FDA Right To Try Policy: For Now, Defer Questions To Sponsors, Bill Text
Right-To-Try Bill Heads To White House, Putting Firms In Driver's Seat

Topics

Advertisement
UsernamePublicRestriction

Register

PS123273

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel